No data available
No data available
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across academia, biotech, and the largest biopharma, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, genetic medicines, cell therapies, peptides, and drug delivery. Partners may access all current and future technologies through a discovery service relationship or for a flat annual fee through Alloy’s Innovation Subscriptions offering. As a reflection of Alloy’s relentless commitment to the scientific community, Alloy reinvests 100% of its revenue in innovation and access to innovation. Alloy is headquartered in Boston, MA, with labs in Cambridge, UK; Basel, CH; San Francisco, CA; and Athens, GA. To learn how to collaborate with Alloy, connect with us at: alloytx.com/contact
Alpha MD is a multi-disciplinary Healthcare and Life Sciences consultancy with offices in London, Mumbai and Philadelphia. We specialise in early stage market access; research, development and regulatory affairs; and Business Intelligence in healthcare and life sciences. This can include putting together teams for stage one or stage two trials, organising trials for medical devices, and business analytics.
We also have a doctor-patient facing app “Liberate Health” which captures everything that happens during a face to face consultation between doctor and patient, and allows the doctor to send the consultation to the patient by e mail. The patient can review the consultation as many times as they wish. This increases efficacy and patient education. Liberate is especially good for the elderly, infirm, marginalised and those with low levels of health education. Liberate also leaves an EHR.
As a part of our Pre-clinical offering, Alpha MD helps in human biospecimen procurement. We source and deliver leading edge, high quality biospecimens covering the Asian population. We specialise in the procurement of diseased and normal, fresh and frozen blood; FFPE, fresh and frozen tissue; serum, plasma, urine and other biofluids. We collect biomaterials covering all major disease targets in Oncology, Autoimmune and Metabolic disorders, Neurology, Kidney diseases, Pulmonology, Infectious diseases, OB/GYN and others.
We also work with “Clinerion”, a piece of software which is attached to an EHR and is proven to quickly identify patients for clinical trials.
Douglas Barrett – Alpha MD. douglas.barrett@sky.com
Watch our Member Showcase video here https://bit.ly/3nJdnGL
We also have a doctor-patient facing app “Liberate Health” which captures everything that happens during a face to face consultation between doctor and patient, and allows the doctor to send the consultation to the patient by e mail. The patient can review the consultation as many times as they wish. This increases efficacy and patient education. Liberate is especially good for the elderly, infirm, marginalised and those with low levels of health education. Liberate also leaves an EHR.
As a part of our Pre-clinical offering, Alpha MD helps in human biospecimen procurement. We source and deliver leading edge, high quality biospecimens covering the Asian population. We specialise in the procurement of diseased and normal, fresh and frozen blood; FFPE, fresh and frozen tissue; serum, plasma, urine and other biofluids. We collect biomaterials covering all major disease targets in Oncology, Autoimmune and Metabolic disorders, Neurology, Kidney diseases, Pulmonology, Infectious diseases, OB/GYN and others.
We also work with “Clinerion”, a piece of software which is attached to an EHR and is proven to quickly identify patients for clinical trials.
Douglas Barrett – Alpha MD. douglas.barrett@sky.com
Watch our Member Showcase video here https://bit.ly/3nJdnGL
Owned by Novo Holdings, Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. Headquartered in Canada, Altasciences has 9 research facilities across North America.
Altasciences’ full-service solutions include preclinical safety testing, bioanalysis, clinical pharmacology, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.
Specific to preclinical research services, Altasciences' expertise spans a wide range of non-GLP and GLP CTA/IND-enabling in vivo safety assessment solutions in both rodent and non-rodent species to thoroughly evaluate pharmaceuticals, biologics, animal health products, agrochemicals, and biocides.
Our scientific and regulatory teams work with you to develop customised research programmes and to ensure that your IND/NDA-enabling toxicology, safety pharmacology, and laboratory studies comply with global regulations.
From lead candidate selection to clinical proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing, and analytical services.
Altasciences’ full-service solutions include preclinical safety testing, bioanalysis, clinical pharmacology, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.
Specific to preclinical research services, Altasciences' expertise spans a wide range of non-GLP and GLP CTA/IND-enabling in vivo safety assessment solutions in both rodent and non-rodent species to thoroughly evaluate pharmaceuticals, biologics, animal health products, agrochemicals, and biocides.
Our scientific and regulatory teams work with you to develop customised research programmes and to ensure that your IND/NDA-enabling toxicology, safety pharmacology, and laboratory studies comply with global regulations.
From lead candidate selection to clinical proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing, and analytical services.
AMSBIO supplies research products and custom services to the biological and pharmaceutical industries. We sell products for routine laboratory procedures as well as more specific, cutting-edge technology. Areas of specific expertise include physiologically realistic cell culture (including 3D culture), tissues and biorepositories, Zymolyase, glycobiology, lentivirus, ELISA kits and stem cell technology. We also offer custom services in protein expression, histochemistry, peptide/antibody design and 3D culture. With offices in the UK, Germany, Switzerland and the USA, AMSBIO offers fast delivery of material. For more information, please visit https://www.amsbio.com or contact AMSBIO’s multilingual help team.
Watch our Member Showcase video here https://bit.ly/3HZMe9T
Watch our Member Showcase video here https://bit.ly/3HZMe9T
Photobiotics is developing an antibody-drug conjugation platform called OptiLink which enhances an antibody fragment's ability to be chemically loaded with therapeutic drugs or imaging agents. This results in high drug loading, more favourable drug-like properties and appropriate pharmacokinetics. Our lead product is an antibody-directed phototherapy (ADP) drug, which targets tumours and is activated by a laser. Our skills lie in antibody engineering and novel drug design/synthesis. We are working with academic groups, biotech companies and pharmaceutical companies to add value to their technologies and looking for further opportunities.
Insurance brokerage. . Insurance Brokerage and Consulting Businesses: Aon Group, Inc Aon Consulting Worldwide, Inc. Aon Services Group. . Insurance brokerage Consulting Consumer underwriting
Longer form - Apollo Therapeutics is a collaborative venture between three world-leading UK universities (Imperial College London, UCL and the University of Cambridge) and three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation). Apollo provides committed translational funding and drug discovery expertise for novel therapeutics, sourced from the best of British academic research, accelerating them towards the clinic.. . Apollo’s unique model provides quick, independent access to the resources to grow innovations and to champion the best of British academic research to industry. Apollo’s experienced team of industry scientists have a proven track record of therapeutic delivery and work in partnership with academics and industry partners, crafting each bespoke project to optimise the chances of long-term success. Apollo Therapeutics aims to create the therapies of the future by partnering with the UK’s globally leading academic science base and UK based Pharma industry to have a real impact on patient treatments and outcomes.
Appleyard Lees is a leading intellectual property law firm with over sixty patent and trade mark attorneys and litigators.
Who we are and what we do – but also, how we do it – makes us distinctive.
We help our clients protect and monetise their intellectual property, and manage post-grant challenges, should they arise.
We offer broad sector and industry knowledge, plus the ability to adapt our services to specific client requirements, in an agile way.
With offices in UK innovation hotspots, we are positioned to give clients expert strategic IP advice in the UK and worldwide.
Who we are and what we do – but also, how we do it – makes us distinctive.
We help our clients protect and monetise their intellectual property, and manage post-grant challenges, should they arise.
We offer broad sector and industry knowledge, plus the ability to adapt our services to specific client requirements, in an agile way.
With offices in UK innovation hotspots, we are positioned to give clients expert strategic IP advice in the UK and worldwide.